Artificial Organ & Bionics Comprehensive Study by Type (Artificial Heart, Liver, Kidney, Bionic Limbs, Heart Valves, Cardiac, Vision), Fixation Method (Implantable, Externally Worn), Technology (Mechanical Bionics, Electronic Bionics), End User (Hospital, Clinic, Others) Players and Region - Global Market Outlook to 2028

Artificial Organ & Bionics Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 8.7%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Artificial Organs are made by a human. Artificial Organs are implemented in human bodies with living tissue, it can able to perform the original function of human body parts. Bionics refers to replacement or improvement of body parts by mechanical kinds. Artificial organs composed of the plastic that is planted with stem cells from the relocate receiver, hence the body’s immune system does not discard the artificial organ. Adoption of Technological advancement and rising number of accidents will help to boost global artificial organ and Bionics market.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia- Pacific
UnitValue (USD Million)
Key Companies ProfiledAbiomed (United States), Asahi Kasei Kuraray Medical (Japan), Thoratec (United States), WorldHeart Fedration (Geneva), Gambro AB (United States), Berlin Heart GmbH (Germany), Boston Scientific Corporation (United States), Cochlear Limited (Australia), Edward Lifesciences (United States) and Orthofix International N.V. (The Netherlands)


According to AMA, the market for Artificial Organ & Bionics is expected to register a CAGR of 8.7% during the forecast period to 2028. This growth is primarily driven by Upsurging Demand of Potential Organs, Rising Number of Healthcare Expenditure and Increasing Number of Accidents.

Globally, a noticeable market trend is evident Adoption of Technological Advancement The Health Care Technology sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Abiomed (United States), Asahi Kasei Kuraray Medical (Japan), Thoratec (United States), WorldHeart Fedration (Geneva), Gambro AB (United States), Berlin Heart GmbH (Germany), Boston Scientific Corporation (United States), Cochlear Limited (Australia), Edward Lifesciences (United States) and Orthofix International N.V. (The Netherlands), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 1st August 2018, CARMAT the designer and developer of the world's most advanced total artificial heart project has announced successful transplant of a donor's heart in the first international patient implanted with the CARMAT heart in October 2017.
On 11th January 2018, Boston Scientific Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System.

Influencing Trend:
Adoption of Technological Advancement and Government Initiation towards Research and Development Activities

Market Growth Drivers:
Upsurging Demand of Potential Organs, Rising Number of Healthcare Expenditure and Increasing Number of Accidents

Challenges:
Government Policies Related to Organ Transplant

Restraints:
High Cost of Organ Transplantation and Lack of Hospitals for Artificial Organ Transplant Facility

Opportunities:
Increasing Awareness about Artificial Organ & Bionics will Create Opportunity

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Artificial Organ & Bionics Market
- Analysis about New Entrants in Artificial Organ & Bionics Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Artificial Organ & Bionics Study Sheds Light on
— The Artificial Organ & Bionics Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Artificial Organ & Bionics industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Artificial Organ & Bionics industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Artificial Heart
  • Liver
  • Kidney
  • Bionic Limbs
  • Heart Valves
  • Cardiac
  • Vision
By Fixation Method
  • Implantable
  • Externally Worn

By Technology
  • Mechanical Bionics
  • Electronic Bionics

By End User
  • Hospital
  • Clinic
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Upsurging Demand of Potential Organs
      • 3.2.2. Rising Number of Healthcare Expenditure
      • 3.2.3. Increasing Number of Accidents
    • 3.3. Market Challenges
      • 3.3.1. Government Policies Related to Organ Transplant
    • 3.4. Market Trends
      • 3.4.1. Adoption of Technological Advancement
      • 3.4.2. Government Initiation towards Research and Development Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Organ & Bionics, by Type, Fixation Method, Technology, End User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial Organ & Bionics (Value)
      • 5.2.1. Global Artificial Organ & Bionics by: Type (Value)
        • 5.2.1.1. Artificial Heart
        • 5.2.1.2. Liver
        • 5.2.1.3. Kidney
        • 5.2.1.4. Bionic Limbs
        • 5.2.1.5. Heart Valves
        • 5.2.1.6. Cardiac
        • 5.2.1.7. Vision
      • 5.2.2. Global Artificial Organ & Bionics by: Fixation Method (Value)
        • 5.2.2.1. Implantable
        • 5.2.2.2. Externally Worn
      • 5.2.3. Global Artificial Organ & Bionics by: Technology (Value)
        • 5.2.3.1. Mechanical Bionics
        • 5.2.3.2. Electronic Bionics
      • 5.2.4. Global Artificial Organ & Bionics by: End User (Value)
        • 5.2.4.1. Hospital
        • 5.2.4.2. Clinic
        • 5.2.4.3. Others
      • 5.2.5. Global Artificial Organ & Bionics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Artificial Organ & Bionics (Volume)
      • 5.3.1. Global Artificial Organ & Bionics by: Type (Volume)
        • 5.3.1.1. Artificial Heart
        • 5.3.1.2. Liver
        • 5.3.1.3. Kidney
        • 5.3.1.4. Bionic Limbs
        • 5.3.1.5. Heart Valves
        • 5.3.1.6. Cardiac
        • 5.3.1.7. Vision
      • 5.3.2. Global Artificial Organ & Bionics by: Fixation Method (Volume)
        • 5.3.2.1. Implantable
        • 5.3.2.2. Externally Worn
      • 5.3.3. Global Artificial Organ & Bionics by: Technology (Volume)
        • 5.3.3.1. Mechanical Bionics
        • 5.3.3.2. Electronic Bionics
      • 5.3.4. Global Artificial Organ & Bionics by: End User (Volume)
        • 5.3.4.1. Hospital
        • 5.3.4.2. Clinic
        • 5.3.4.3. Others
      • 5.3.5. Global Artificial Organ & Bionics Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Artificial Organ & Bionics (Price)
      • 5.4.1. Global Artificial Organ & Bionics by: Type (Price)
  • 6. Artificial Organ & Bionics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abiomed (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Asahi Kasei Kuraray Medical (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thoratec (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. WorldHeart Fedration (Geneva)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Gambro AB (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Berlin Heart GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cochlear Limited (Australia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Edward Lifesciences (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Orthofix International N.V. (The Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Artificial Organ & Bionics Sale, by Type, Fixation Method, Technology, End User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial Organ & Bionics (Value)
      • 7.2.1. Global Artificial Organ & Bionics by: Type (Value)
        • 7.2.1.1. Artificial Heart
        • 7.2.1.2. Liver
        • 7.2.1.3. Kidney
        • 7.2.1.4. Bionic Limbs
        • 7.2.1.5. Heart Valves
        • 7.2.1.6. Cardiac
        • 7.2.1.7. Vision
      • 7.2.2. Global Artificial Organ & Bionics by: Fixation Method (Value)
        • 7.2.2.1. Implantable
        • 7.2.2.2. Externally Worn
      • 7.2.3. Global Artificial Organ & Bionics by: Technology (Value)
        • 7.2.3.1. Mechanical Bionics
        • 7.2.3.2. Electronic Bionics
      • 7.2.4. Global Artificial Organ & Bionics by: End User (Value)
        • 7.2.4.1. Hospital
        • 7.2.4.2. Clinic
        • 7.2.4.3. Others
      • 7.2.5. Global Artificial Organ & Bionics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Artificial Organ & Bionics (Volume)
      • 7.3.1. Global Artificial Organ & Bionics by: Type (Volume)
        • 7.3.1.1. Artificial Heart
        • 7.3.1.2. Liver
        • 7.3.1.3. Kidney
        • 7.3.1.4. Bionic Limbs
        • 7.3.1.5. Heart Valves
        • 7.3.1.6. Cardiac
        • 7.3.1.7. Vision
      • 7.3.2. Global Artificial Organ & Bionics by: Fixation Method (Volume)
        • 7.3.2.1. Implantable
        • 7.3.2.2. Externally Worn
      • 7.3.3. Global Artificial Organ & Bionics by: Technology (Volume)
        • 7.3.3.1. Mechanical Bionics
        • 7.3.3.2. Electronic Bionics
      • 7.3.4. Global Artificial Organ & Bionics by: End User (Volume)
        • 7.3.4.1. Hospital
        • 7.3.4.2. Clinic
        • 7.3.4.3. Others
      • 7.3.5. Global Artificial Organ & Bionics Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Artificial Organ & Bionics (Price)
      • 7.4.1. Global Artificial Organ & Bionics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Organ & Bionics: by Type(USD Million)
  • Table 2. Artificial Organ & Bionics Artificial Heart , by Region USD Million (2017-2022)
  • Table 3. Artificial Organ & Bionics Liver , by Region USD Million (2017-2022)
  • Table 4. Artificial Organ & Bionics Kidney , by Region USD Million (2017-2022)
  • Table 5. Artificial Organ & Bionics Bionic Limbs , by Region USD Million (2017-2022)
  • Table 6. Artificial Organ & Bionics Heart Valves , by Region USD Million (2017-2022)
  • Table 7. Artificial Organ & Bionics Cardiac , by Region USD Million (2017-2022)
  • Table 8. Artificial Organ & Bionics Vision , by Region USD Million (2017-2022)
  • Table 9. Artificial Organ & Bionics: by Fixation Method(USD Million)
  • Table 10. Artificial Organ & Bionics Implantable , by Region USD Million (2017-2022)
  • Table 11. Artificial Organ & Bionics Externally Worn , by Region USD Million (2017-2022)
  • Table 12. Artificial Organ & Bionics: by Technology(USD Million)
  • Table 13. Artificial Organ & Bionics Mechanical Bionics , by Region USD Million (2017-2022)
  • Table 14. Artificial Organ & Bionics Electronic Bionics , by Region USD Million (2017-2022)
  • Table 15. Artificial Organ & Bionics: by End User(USD Million)
  • Table 16. Artificial Organ & Bionics Hospital , by Region USD Million (2017-2022)
  • Table 17. Artificial Organ & Bionics Clinic , by Region USD Million (2017-2022)
  • Table 18. Artificial Organ & Bionics Others , by Region USD Million (2017-2022)
  • Table 19. South America Artificial Organ & Bionics, by Country USD Million (2017-2022)
  • Table 20. South America Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 21. South America Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 22. South America Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 23. South America Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 24. Brazil Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 25. Brazil Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 26. Brazil Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 27. Brazil Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 28. Argentina Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 29. Argentina Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 30. Argentina Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 31. Argentina Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 32. Rest of South America Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 33. Rest of South America Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 34. Rest of South America Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 35. Rest of South America Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 36. Asia Pacific Artificial Organ & Bionics, by Country USD Million (2017-2022)
  • Table 37. Asia Pacific Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 38. Asia Pacific Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 39. Asia Pacific Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 40. Asia Pacific Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 41. China Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 42. China Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 43. China Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 44. China Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 45. Japan Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 46. Japan Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 47. Japan Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 48. Japan Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 49. India Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 50. India Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 51. India Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 52. India Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 53. South Korea Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 54. South Korea Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 55. South Korea Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 56. South Korea Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 57. Taiwan Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 58. Taiwan Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 59. Taiwan Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 60. Taiwan Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 61. Australia Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 62. Australia Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 63. Australia Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 64. Australia Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 69. Europe Artificial Organ & Bionics, by Country USD Million (2017-2022)
  • Table 70. Europe Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 71. Europe Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 72. Europe Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 73. Europe Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 74. Germany Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 75. Germany Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 76. Germany Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 77. Germany Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 78. France Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 79. France Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 80. France Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 81. France Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 82. Italy Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 83. Italy Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 84. Italy Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 85. Italy Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 86. United Kingdom Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 87. United Kingdom Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 88. United Kingdom Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 89. United Kingdom Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 90. Netherlands Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 91. Netherlands Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 92. Netherlands Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 93. Netherlands Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 94. Rest of Europe Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 95. Rest of Europe Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 96. Rest of Europe Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 97. Rest of Europe Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 98. MEA Artificial Organ & Bionics, by Country USD Million (2017-2022)
  • Table 99. MEA Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 100. MEA Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 101. MEA Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 102. MEA Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 103. Middle East Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 104. Middle East Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 105. Middle East Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 106. Middle East Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 107. Africa Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 108. Africa Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 109. Africa Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 110. Africa Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 111. North America Artificial Organ & Bionics, by Country USD Million (2017-2022)
  • Table 112. North America Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 113. North America Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 114. North America Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 115. North America Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 116. United States Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 117. United States Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 118. United States Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 119. United States Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 120. Canada Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 121. Canada Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 122. Canada Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 123. Canada Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 124. Mexico Artificial Organ & Bionics, by Type USD Million (2017-2022)
  • Table 125. Mexico Artificial Organ & Bionics, by Fixation Method USD Million (2017-2022)
  • Table 126. Mexico Artificial Organ & Bionics, by Technology USD Million (2017-2022)
  • Table 127. Mexico Artificial Organ & Bionics, by End User USD Million (2017-2022)
  • Table 128. Artificial Organ & Bionics Sales: by Type(K Units)
  • Table 129. Artificial Organ & Bionics Sales Artificial Heart , by Region K Units (2017-2022)
  • Table 130. Artificial Organ & Bionics Sales Liver , by Region K Units (2017-2022)
  • Table 131. Artificial Organ & Bionics Sales Kidney , by Region K Units (2017-2022)
  • Table 132. Artificial Organ & Bionics Sales Bionic Limbs , by Region K Units (2017-2022)
  • Table 133. Artificial Organ & Bionics Sales Heart Valves , by Region K Units (2017-2022)
  • Table 134. Artificial Organ & Bionics Sales Cardiac , by Region K Units (2017-2022)
  • Table 135. Artificial Organ & Bionics Sales Vision , by Region K Units (2017-2022)
  • Table 136. Artificial Organ & Bionics Sales: by Fixation Method(K Units)
  • Table 137. Artificial Organ & Bionics Sales Implantable , by Region K Units (2017-2022)
  • Table 138. Artificial Organ & Bionics Sales Externally Worn , by Region K Units (2017-2022)
  • Table 139. Artificial Organ & Bionics Sales: by Technology(K Units)
  • Table 140. Artificial Organ & Bionics Sales Mechanical Bionics , by Region K Units (2017-2022)
  • Table 141. Artificial Organ & Bionics Sales Electronic Bionics , by Region K Units (2017-2022)
  • Table 142. Artificial Organ & Bionics Sales: by End User(K Units)
  • Table 143. Artificial Organ & Bionics Sales Hospital , by Region K Units (2017-2022)
  • Table 144. Artificial Organ & Bionics Sales Clinic , by Region K Units (2017-2022)
  • Table 145. Artificial Organ & Bionics Sales Others , by Region K Units (2017-2022)
  • Table 146. South America Artificial Organ & Bionics Sales, by Country K Units (2017-2022)
  • Table 147. South America Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 148. South America Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 149. South America Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 150. South America Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 151. Brazil Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 152. Brazil Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 153. Brazil Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 154. Brazil Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 155. Argentina Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 156. Argentina Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 157. Argentina Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 158. Argentina Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 159. Rest of South America Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 160. Rest of South America Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 161. Rest of South America Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 162. Rest of South America Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 163. Asia Pacific Artificial Organ & Bionics Sales, by Country K Units (2017-2022)
  • Table 164. Asia Pacific Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 165. Asia Pacific Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 166. Asia Pacific Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 167. Asia Pacific Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 168. China Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 169. China Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 170. China Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 171. China Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 172. Japan Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 173. Japan Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 174. Japan Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 175. Japan Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 176. India Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 177. India Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 178. India Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 179. India Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 180. South Korea Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 181. South Korea Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 182. South Korea Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 183. South Korea Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 184. Taiwan Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 185. Taiwan Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 186. Taiwan Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 187. Taiwan Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 188. Australia Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 189. Australia Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 190. Australia Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 191. Australia Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 192. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 193. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 194. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 195. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 196. Europe Artificial Organ & Bionics Sales, by Country K Units (2017-2022)
  • Table 197. Europe Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 198. Europe Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 199. Europe Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 200. Europe Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 201. Germany Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 202. Germany Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 203. Germany Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 204. Germany Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 205. France Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 206. France Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 207. France Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 208. France Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 209. Italy Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 210. Italy Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 211. Italy Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 212. Italy Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 213. United Kingdom Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 214. United Kingdom Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 215. United Kingdom Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 216. United Kingdom Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 217. Netherlands Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 218. Netherlands Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 219. Netherlands Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 220. Netherlands Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 221. Rest of Europe Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 222. Rest of Europe Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 223. Rest of Europe Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 224. Rest of Europe Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 225. MEA Artificial Organ & Bionics Sales, by Country K Units (2017-2022)
  • Table 226. MEA Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 227. MEA Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 228. MEA Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 229. MEA Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 230. Middle East Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 231. Middle East Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 232. Middle East Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 233. Middle East Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 234. Africa Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 235. Africa Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 236. Africa Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 237. Africa Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 238. North America Artificial Organ & Bionics Sales, by Country K Units (2017-2022)
  • Table 239. North America Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 240. North America Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 241. North America Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 242. North America Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 243. United States Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 244. United States Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 245. United States Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 246. United States Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 247. Canada Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 248. Canada Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 249. Canada Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 250. Canada Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 251. Mexico Artificial Organ & Bionics Sales, by Type K Units (2017-2022)
  • Table 252. Mexico Artificial Organ & Bionics Sales, by Fixation Method K Units (2017-2022)
  • Table 253. Mexico Artificial Organ & Bionics Sales, by Technology K Units (2017-2022)
  • Table 254. Mexico Artificial Organ & Bionics Sales, by End User K Units (2017-2022)
  • Table 255. Artificial Organ & Bionics: by Type(USD/Units)
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Artificial Organ & Bionics: by Type(USD Million)
  • Table 267. Artificial Organ & Bionics Artificial Heart , by Region USD Million (2023-2028)
  • Table 268. Artificial Organ & Bionics Liver , by Region USD Million (2023-2028)
  • Table 269. Artificial Organ & Bionics Kidney , by Region USD Million (2023-2028)
  • Table 270. Artificial Organ & Bionics Bionic Limbs , by Region USD Million (2023-2028)
  • Table 271. Artificial Organ & Bionics Heart Valves , by Region USD Million (2023-2028)
  • Table 272. Artificial Organ & Bionics Cardiac , by Region USD Million (2023-2028)
  • Table 273. Artificial Organ & Bionics Vision , by Region USD Million (2023-2028)
  • Table 274. Artificial Organ & Bionics: by Fixation Method(USD Million)
  • Table 275. Artificial Organ & Bionics Implantable , by Region USD Million (2023-2028)
  • Table 276. Artificial Organ & Bionics Externally Worn , by Region USD Million (2023-2028)
  • Table 277. Artificial Organ & Bionics: by Technology(USD Million)
  • Table 278. Artificial Organ & Bionics Mechanical Bionics , by Region USD Million (2023-2028)
  • Table 279. Artificial Organ & Bionics Electronic Bionics , by Region USD Million (2023-2028)
  • Table 280. Artificial Organ & Bionics: by End User(USD Million)
  • Table 281. Artificial Organ & Bionics Hospital , by Region USD Million (2023-2028)
  • Table 282. Artificial Organ & Bionics Clinic , by Region USD Million (2023-2028)
  • Table 283. Artificial Organ & Bionics Others , by Region USD Million (2023-2028)
  • Table 284. South America Artificial Organ & Bionics, by Country USD Million (2023-2028)
  • Table 285. South America Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 286. South America Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 287. South America Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 288. South America Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 289. Brazil Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 290. Brazil Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 291. Brazil Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 292. Brazil Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 293. Argentina Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 294. Argentina Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 295. Argentina Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 296. Argentina Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 297. Rest of South America Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 298. Rest of South America Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 299. Rest of South America Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 300. Rest of South America Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 301. Asia Pacific Artificial Organ & Bionics, by Country USD Million (2023-2028)
  • Table 302. Asia Pacific Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 303. Asia Pacific Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 304. Asia Pacific Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 305. Asia Pacific Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 306. China Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 307. China Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 308. China Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 309. China Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 310. Japan Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 311. Japan Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 312. Japan Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 313. Japan Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 314. India Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 315. India Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 316. India Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 317. India Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 318. South Korea Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 319. South Korea Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 320. South Korea Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 321. South Korea Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 322. Taiwan Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 323. Taiwan Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 324. Taiwan Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 325. Taiwan Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 326. Australia Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 327. Australia Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 328. Australia Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 329. Australia Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 330. Rest of Asia-Pacific Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 331. Rest of Asia-Pacific Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 332. Rest of Asia-Pacific Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 333. Rest of Asia-Pacific Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 334. Europe Artificial Organ & Bionics, by Country USD Million (2023-2028)
  • Table 335. Europe Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 336. Europe Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 337. Europe Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 338. Europe Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 339. Germany Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 340. Germany Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 341. Germany Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 342. Germany Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 343. France Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 344. France Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 345. France Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 346. France Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 347. Italy Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 348. Italy Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 349. Italy Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 350. Italy Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 351. United Kingdom Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 352. United Kingdom Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 353. United Kingdom Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 354. United Kingdom Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 355. Netherlands Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 356. Netherlands Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 357. Netherlands Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 358. Netherlands Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 359. Rest of Europe Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 360. Rest of Europe Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 361. Rest of Europe Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 362. Rest of Europe Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 363. MEA Artificial Organ & Bionics, by Country USD Million (2023-2028)
  • Table 364. MEA Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 365. MEA Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 366. MEA Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 367. MEA Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 368. Middle East Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 369. Middle East Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 370. Middle East Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 371. Middle East Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 372. Africa Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 373. Africa Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 374. Africa Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 375. Africa Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 376. North America Artificial Organ & Bionics, by Country USD Million (2023-2028)
  • Table 377. North America Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 378. North America Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 379. North America Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 380. North America Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 381. United States Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 382. United States Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 383. United States Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 384. United States Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 385. Canada Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 386. Canada Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 387. Canada Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 388. Canada Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 389. Mexico Artificial Organ & Bionics, by Type USD Million (2023-2028)
  • Table 390. Mexico Artificial Organ & Bionics, by Fixation Method USD Million (2023-2028)
  • Table 391. Mexico Artificial Organ & Bionics, by Technology USD Million (2023-2028)
  • Table 392. Mexico Artificial Organ & Bionics, by End User USD Million (2023-2028)
  • Table 393. Artificial Organ & Bionics Sales: by Type(K Units)
  • Table 394. Artificial Organ & Bionics Sales Artificial Heart , by Region K Units (2023-2028)
  • Table 395. Artificial Organ & Bionics Sales Liver , by Region K Units (2023-2028)
  • Table 396. Artificial Organ & Bionics Sales Kidney , by Region K Units (2023-2028)
  • Table 397. Artificial Organ & Bionics Sales Bionic Limbs , by Region K Units (2023-2028)
  • Table 398. Artificial Organ & Bionics Sales Heart Valves , by Region K Units (2023-2028)
  • Table 399. Artificial Organ & Bionics Sales Cardiac , by Region K Units (2023-2028)
  • Table 400. Artificial Organ & Bionics Sales Vision , by Region K Units (2023-2028)
  • Table 401. Artificial Organ & Bionics Sales: by Fixation Method(K Units)
  • Table 402. Artificial Organ & Bionics Sales Implantable , by Region K Units (2023-2028)
  • Table 403. Artificial Organ & Bionics Sales Externally Worn , by Region K Units (2023-2028)
  • Table 404. Artificial Organ & Bionics Sales: by Technology(K Units)
  • Table 405. Artificial Organ & Bionics Sales Mechanical Bionics , by Region K Units (2023-2028)
  • Table 406. Artificial Organ & Bionics Sales Electronic Bionics , by Region K Units (2023-2028)
  • Table 407. Artificial Organ & Bionics Sales: by End User(K Units)
  • Table 408. Artificial Organ & Bionics Sales Hospital , by Region K Units (2023-2028)
  • Table 409. Artificial Organ & Bionics Sales Clinic , by Region K Units (2023-2028)
  • Table 410. Artificial Organ & Bionics Sales Others , by Region K Units (2023-2028)
  • Table 411. South America Artificial Organ & Bionics Sales, by Country K Units (2023-2028)
  • Table 412. South America Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 413. South America Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 414. South America Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 415. South America Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 416. Brazil Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 417. Brazil Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 418. Brazil Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 419. Brazil Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 420. Argentina Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 421. Argentina Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 422. Argentina Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 423. Argentina Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 424. Rest of South America Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 425. Rest of South America Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 426. Rest of South America Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 427. Rest of South America Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 428. Asia Pacific Artificial Organ & Bionics Sales, by Country K Units (2023-2028)
  • Table 429. Asia Pacific Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 430. Asia Pacific Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 431. Asia Pacific Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 432. Asia Pacific Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 433. China Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 434. China Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 435. China Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 436. China Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 437. Japan Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 438. Japan Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 439. Japan Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 440. Japan Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 441. India Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 442. India Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 443. India Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 444. India Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 445. South Korea Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 446. South Korea Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 447. South Korea Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 448. South Korea Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 449. Taiwan Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 450. Taiwan Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 451. Taiwan Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 452. Taiwan Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 453. Australia Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 454. Australia Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 455. Australia Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 456. Australia Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 457. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 458. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 459. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 460. Rest of Asia-Pacific Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 461. Europe Artificial Organ & Bionics Sales, by Country K Units (2023-2028)
  • Table 462. Europe Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 463. Europe Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 464. Europe Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 465. Europe Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 466. Germany Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 467. Germany Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 468. Germany Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 469. Germany Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 470. France Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 471. France Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 472. France Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 473. France Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 474. Italy Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 475. Italy Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 476. Italy Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 477. Italy Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 478. United Kingdom Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 479. United Kingdom Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 480. United Kingdom Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 481. United Kingdom Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 482. Netherlands Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 483. Netherlands Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 484. Netherlands Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 485. Netherlands Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 486. Rest of Europe Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 487. Rest of Europe Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 488. Rest of Europe Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 489. Rest of Europe Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 490. MEA Artificial Organ & Bionics Sales, by Country K Units (2023-2028)
  • Table 491. MEA Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 492. MEA Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 493. MEA Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 494. MEA Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 495. Middle East Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 496. Middle East Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 497. Middle East Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 498. Middle East Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 499. Africa Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 500. Africa Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 501. Africa Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 502. Africa Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 503. North America Artificial Organ & Bionics Sales, by Country K Units (2023-2028)
  • Table 504. North America Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 505. North America Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 506. North America Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 507. North America Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 508. United States Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 509. United States Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 510. United States Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 511. United States Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 512. Canada Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 513. Canada Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 514. Canada Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 515. Canada Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 516. Mexico Artificial Organ & Bionics Sales, by Type K Units (2023-2028)
  • Table 517. Mexico Artificial Organ & Bionics Sales, by Fixation Method K Units (2023-2028)
  • Table 518. Mexico Artificial Organ & Bionics Sales, by Technology K Units (2023-2028)
  • Table 519. Mexico Artificial Organ & Bionics Sales, by End User K Units (2023-2028)
  • Table 520. Artificial Organ & Bionics: by Type(USD/Units)
  • Table 521. Research Programs/Design for This Report
  • Table 522. Key Data Information from Secondary Sources
  • Table 523. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Organ & Bionics: by Type USD Million (2017-2022)
  • Figure 5. Global Artificial Organ & Bionics: by Fixation Method USD Million (2017-2022)
  • Figure 6. Global Artificial Organ & Bionics: by Technology USD Million (2017-2022)
  • Figure 7. Global Artificial Organ & Bionics: by End User USD Million (2017-2022)
  • Figure 8. South America Artificial Organ & Bionics Share (%), by Country
  • Figure 9. Asia Pacific Artificial Organ & Bionics Share (%), by Country
  • Figure 10. Europe Artificial Organ & Bionics Share (%), by Country
  • Figure 11. MEA Artificial Organ & Bionics Share (%), by Country
  • Figure 12. North America Artificial Organ & Bionics Share (%), by Country
  • Figure 13. Global Artificial Organ & Bionics: by Type K Units (2017-2022)
  • Figure 14. Global Artificial Organ & Bionics: by Fixation Method K Units (2017-2022)
  • Figure 15. Global Artificial Organ & Bionics: by Technology K Units (2017-2022)
  • Figure 16. Global Artificial Organ & Bionics: by End User K Units (2017-2022)
  • Figure 17. South America Artificial Organ & Bionics Share (%), by Country
  • Figure 18. Asia Pacific Artificial Organ & Bionics Share (%), by Country
  • Figure 19. Europe Artificial Organ & Bionics Share (%), by Country
  • Figure 20. MEA Artificial Organ & Bionics Share (%), by Country
  • Figure 21. North America Artificial Organ & Bionics Share (%), by Country
  • Figure 22. Global Artificial Organ & Bionics: by Type USD/Units (2017-2022)
  • Figure 23. Global Artificial Organ & Bionics share by Players 2022 (%)
  • Figure 24. Global Artificial Organ & Bionics share by Players (Top 3) 2022(%)
  • Figure 25. Global Artificial Organ & Bionics share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Abiomed (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abiomed (United States) Revenue: by Geography 2022
  • Figure 29. Asahi Kasei Kuraray Medical (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Asahi Kasei Kuraray Medical (Japan) Revenue: by Geography 2022
  • Figure 31. Thoratec (United States) Revenue, Net Income and Gross profit
  • Figure 32. Thoratec (United States) Revenue: by Geography 2022
  • Figure 33. WorldHeart Fedration (Geneva) Revenue, Net Income and Gross profit
  • Figure 34. WorldHeart Fedration (Geneva) Revenue: by Geography 2022
  • Figure 35. Gambro AB (United States) Revenue, Net Income and Gross profit
  • Figure 36. Gambro AB (United States) Revenue: by Geography 2022
  • Figure 37. Berlin Heart GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Berlin Heart GmbH (Germany) Revenue: by Geography 2022
  • Figure 39. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 41. Cochlear Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 42. Cochlear Limited (Australia) Revenue: by Geography 2022
  • Figure 43. Edward Lifesciences (United States) Revenue, Net Income and Gross profit
  • Figure 44. Edward Lifesciences (United States) Revenue: by Geography 2022
  • Figure 45. Orthofix International N.V. (The Netherlands) Revenue, Net Income and Gross profit
  • Figure 46. Orthofix International N.V. (The Netherlands) Revenue: by Geography 2022
  • Figure 47. Global Artificial Organ & Bionics: by Type USD Million (2023-2028)
  • Figure 48. Global Artificial Organ & Bionics: by Fixation Method USD Million (2023-2028)
  • Figure 49. Global Artificial Organ & Bionics: by Technology USD Million (2023-2028)
  • Figure 50. Global Artificial Organ & Bionics: by End User USD Million (2023-2028)
  • Figure 51. South America Artificial Organ & Bionics Share (%), by Country
  • Figure 52. Asia Pacific Artificial Organ & Bionics Share (%), by Country
  • Figure 53. Europe Artificial Organ & Bionics Share (%), by Country
  • Figure 54. MEA Artificial Organ & Bionics Share (%), by Country
  • Figure 55. North America Artificial Organ & Bionics Share (%), by Country
  • Figure 56. Global Artificial Organ & Bionics: by Type K Units (2023-2028)
  • Figure 57. Global Artificial Organ & Bionics: by Fixation Method K Units (2023-2028)
  • Figure 58. Global Artificial Organ & Bionics: by Technology K Units (2023-2028)
  • Figure 59. Global Artificial Organ & Bionics: by End User K Units (2023-2028)
  • Figure 60. South America Artificial Organ & Bionics Share (%), by Country
  • Figure 61. Asia Pacific Artificial Organ & Bionics Share (%), by Country
  • Figure 62. Europe Artificial Organ & Bionics Share (%), by Country
  • Figure 63. MEA Artificial Organ & Bionics Share (%), by Country
  • Figure 64. North America Artificial Organ & Bionics Share (%), by Country
  • Figure 65. Global Artificial Organ & Bionics: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Abiomed (United States)
  • Asahi Kasei Kuraray Medical (Japan)
  • Thoratec (United States)
  • WorldHeart Fedration (Geneva)
  • Gambro AB (United States)
  • Berlin Heart GmbH (Germany)
  • Boston Scientific Corporation (United States)
  • Cochlear Limited (Australia)
  • Edward Lifesciences (United States)
  • Orthofix International N.V. (The Netherlands)
Additional players considered in the study are as follows:
Biomet, Inc. (United States) , Medtronic, Inc. (United States) , Second Sight Medical Products, Inc. (United States) , Ossur (Iceland) , Ekso Bionics (United States) , St. Jude Medical, Inc. (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 217 Pages 71 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Artificial Organ & Bionics market are Abiomed (United States), Asahi Kasei Kuraray Medical (Japan), Thoratec (United States), WorldHeart Fedration (Geneva), Gambro AB (United States), Berlin Heart GmbH (Germany), Boston Scientific Corporation (United States), Cochlear Limited (Australia), Edward Lifesciences (United States) and Orthofix International N.V. (The Netherlands), to name a few.
North America is dominating the Artificial Organ & Bionics Market.
"Government Policies Related to Organ Transplant" is seen as one of the major challenges by many Industry Players of Artificial Organ & Bionics Market
The Artificial Organ & Bionics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Artificial Organ & Bionics market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Artificial Organ & Bionics Market Report?